PRTK - Paratek Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow

Income statement

Annual
All numbers in thousands
Revenue31/12/201731/12/201631/12/201531/12/2014
Total revenue-29-4,342
Cost of revenue60,07283,46050,7655,014
Gross profit-47,456-83,431-50,765-672
Operating expenses
Research development----
Selling general and administrative-26,40019,9885,848
Non-recurring----
Others----
Total operating expenses-109,86070,75310,862
Operating income or loss--109,831-70,753-6,520
Income from continuing operations
Total other income/expenses net-193-1,805-107-11,315
Earnings before interest and taxes--109,831-70,753-6,520
Interest expense--3,223-770-718
Income before tax--111,636-70,860-17,835
Income tax expense----
Minority interest----
Net income from continuing ops--111,636-70,860-17,835
Non-recurring events
Discontinued operations----
Extraordinary items----
Effect of accounting changes----
Other items----
Net income
Net income--111,636-70,860-17,835
Preferred stock and other adjustments----
Net income applicable to common shares--111,636-70,860-19,762